Moderate and severe dementia can benefit from donepezil

NEW research backs continuation of donepezil when patients with Alzheimer’s disease progress to moderate to severe dementia.

A community just for doctors

To continue reading please login or sign up for access.

Start Today

Author:

Rada Rouse

Clinical News Editor

Rada is an award-winning medical journalist and a former president of the Australian Medical Writers Association. Over three decades as a journalist, Rada’s roles have included Canberra press gallery chief-of-staff for the Australian Associated Press and seven years as the national news agency’s medical correspondent. She has been at Medical Observer for more than 10 years and contributes to the news pages of major journals including the BMJ and Nature Medicine.